Soru

Zorluk: OrtaGynecologic Oncology

A 62-year-old woman comes to the office due to a 3-week history of episodic vaginal bleeding. She reached menopause at age 52 and has not had any vaginal bleeding since then. Her medical history is significant for obesity, type 2 diabetes mellitus, and hypertension. Current medications include metformin and lisinopril. Her body mass index (BMI) is 34 kg/m². Pelvic examination shows normal external genitalia and a nulliparous cervix without visible lesions. Bimanual examination reveals a normal-sized, mobile uterus with no adnexal masses. A transvaginal ultrasound is performed and shows an endometrial stripe thickness of 7 mm. Which of the following is the most appropriate next step in management?

  1. A
    Reassurance and observation
  2. B
    Repeat transvaginal ultrasound in 3 months
  3. Endometrial biopsyCevap
  4. D
    Hysteroscopy with endometrial ablation
  5. E
    Total abdominal hysterectomy

Cevap

The most appropriate next step in management is to perform an endometrial biopsy.
The correct answer is endometrial biopsy. The patient presents with postmenopausal bleeding and an endometrial stripe of 7 mm (which is > 4 mm). This presentation is highly suspicious for endometrial hyperplasia or cancer, particularly given her prominent risk factors of obesity, nulliparity, and type 2 diabetes. Tissue diagnosis via an office endometrial biopsy is mandatory to definitively rule out malignancy.

Adım Adım Çözüm

1
Identify the patient's primary presenting symptom and menopausal status.
The patient is a 62-year-old postmenopausal woman with a new onset of abnormal vaginal bleeding.
Postmenopausal bleeding is a major red flag symptom for endometrial carcinoma and requires immediate, thorough evaluation.
2
Evaluate the patient's risk factors for endometrial cancer.
The patient has multiple significant risk factors, including advanced age, obesity, type 2 diabetes, nulliparity, and unopposed estrogen exposure due to peripheral conversion of androgens in adipose tissue.
Recognizing risk factors increases the clinical index of suspicion for an underlying malignancy.
3
Interpret the transvaginal ultrasound (TVUS) findings.
The TVUS shows an endometrial stripe of 7 mm.
An endometrial thickness strictly > 4 mm in a postmenopausal woman is considered abnormal and highly concerning for endometrial hyperplasia or cancer.
4
Determine the next best step in clinical management.
Endometrial biopsy.
Tissue sampling is the gold standard and a mandatory diagnostic step to rule out endometrial adenocarcinoma in the setting of postmenopausal bleeding with a thickened endometrium.

Anahtar Kavram

Any postmenopausal woman presenting with vaginal bleeding and an endometrial stripe thickness strictly greater than 4 mm requires an endometrial biopsy to rule out endometrial carcinoma.
Bu soruyu puanla